Storia in 4 fonti

Sobi receives CRL for gout combination drug over manufacturing

The FDA has issued Sobi, also known as Swedish Orphan Biovitrum, a complete response letter for its combination gout treatment over production concerns and issues with its third-party manufacturing sites.

Raccontata da

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

endpoints.newsStai leggendo1 mese fa

Sobi receives CRL for gout combination drug over manufacturing

originale

Timeline cronologica

venerdì 26 giugno 2026·morningstar.com
Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)
Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)
lunedì 29 giugno 2026·endpoints.news
Sobi receives CRL for gout combination drug over manufacturing
The FDA has issued Sobi, also known as Swedish Orphan Biovitrum, a complete response letter for its combination gout treatment over production concerns and issues with its…

Sobi receives CRL for gout combination drug over manufacturing

Confronto fonti

Sobi receives CRL for gout combination drug over manufacturing

Timeline cronologica

Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)

Sobi receives CRL for gout combination drug over manufacturing

FDA declines to approve novel infusion for uncontrolled gout over manufacturing concerns

FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster

Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)

FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster

FDA declines to approve novel infusion for uncontrolled gout over manufacturing concerns